Ticker > Company >

Symbiox Inv.& Tradig share price

Symbiox Investment & Trading Co Ltd.

BSE: 539278 SECTOR: Trading  10k   32   1

3.43
-0.14 (-3.92%)
BSE: 14 Nov 04:01 PM

Price Summary

Today's High

₹ 3.69

Today's Low

₹ 3.4

52 Week High

₹ 4.53

52 Week Low

₹ 2.35

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

10.73 Cr.

Enterprise Value

10.42 Cr.

No. of Shares

3.13 Cr.

P/E

56.23

P/B

0.34

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  10.08

CASH

0.31 Cr.

DEBT

0 Cr.

Promoter Holding

3.33 %

EPS (TTM)

₹  0.06

Sales Growth

-2.12%

ROE

0.66 %

ROCE

0.79%

Profit Growth

30.88 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-2.12%
3 Year23.31%
5 Year34.15%

Profit Growth

1 Year30.88%
3 Year44.24%
5 Year90.69%

ROE%

1 Year0.66%
3 Year0.54%
5 Year0.38%

ROCE %

1 Year0.79%
3 Year0.69%
5 Year0.5%

Debt/Equity

0

Price to Cash Flow

-3.51

Interest Cover Ratio

340.0573

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 3.33 0.00
Jun 2024 3.33 0.00
Mar 2024 3.33 0.00
Dec 2023 3.33 0.00
Sep 2023 3.33 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 23.3143588994882% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -28.4762 days.
  • Company has a healthy liquidity position with current ratio of 88.3152.

 Limitations

  • Company has a poor ROE of 0.539616180249751% over the past 3 years.
  • Company has a poor ROCE of 0.69477371826882% over the past 3 years
  • Company has negative cash flow from operations of -3.0595949.
  • The company has a low EBITDA margin of -23.6548430513659% over the past 5 years.
  • The company is trading at a high PE of 56.23.
  • The company is trading at a high EV/EBITDA of 100.1885.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 1.23 0.18 1.12 0.31 0.75
Total Expenditure 1.09 0.25 1.22 0.3 0.31
Operating Profit 0.15 -0.07 -0.1 0.01 0.44
Other Income 0.03 0.06 0.03 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.18 -0.01 -0.07 0.01 0.44
Tax 0.05 0 -0.04 0 0.12
Profit After Tax 0.13 -0.01 -0.03 0.01 0.33
Adjusted EPS (Rs) 0.04 0 -0.01 0 0.1

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1.04 2.08 1.83 3.98 3.9
Total Expenditure 1.97 2.99 1.66 3.78 3.88
Operating Profit -0.93 -0.91 0.17 0.2 0.02
Other Income 0.96 1.01 0.01 0.02 0.23
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.03 0.09 0.19 0.22 0.25
Tax 0.01 0.02 0.05 0.06 0.04
Net Profit 0.02 0.07 0.14 0.16 0.21
Adjusted EPS (Rs.) 0.01 0.02 0.04 0.05 0.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 31.29 31.29 31.29 31.29 31.29
Total Reserves -0.39 -0.33 -0.12 0.04 0.24
Borrowings 0.26 0 0 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 0.85 2.32 0.74 1.49 0.36
Total Liabilities 32.01 33.28 31.9 32.81 31.89
Assets
Net Block 0 0 0 0 0.02
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 32 33.27 31.9 32.81 31.87
Total Assets 32.01 33.28 31.9 32.81 31.89
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.03 0.09 0.19 0.22 0.25
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities 0.26 1.07 -0.51 -4.64 -3.25
Tax Paid -0.02 -0.03 -0.02 -0.05 -0.06
Operating Cash Flow 0.27 1.14 -0.35 -4.47 -3.06
Investing Cash Flow -0.38 -1 0.4 4.82 2.83
Financing Cash Flow 0 0 0 0 0
Net Cash Flow -0.11 0.14 0.04 0.35 -0.23

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 3.33 3.33 3.33 3.33 3.33
gaurav audichya 0.13 0.13 0.13 0.13 0.13
tyro commercial private l... 3.20 3.20 3.20 3.20 3.20
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 96.67 96.67 96.67 96.67 96.67
abhilasha singhania 1.28 1.28 1.28 1.28 1.28
mahesh khandelwal - - - - 1.68
ravi kumar newatia(huf) - - - - 1.60
suman chepuri - 1.03 3.10 3.46 1.87
gurjinder singh 1.78 1.73 - 1.45 -
sunil mark fernandes - - - 1.15 -
manish harishchandra desa... 1.27 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Symbiox Investment & Trading Co informs about board meeting 29 Aug, 5:22 PM Symbiox Inv.& Tradig - Quaterly Results 14 Aug, 4:22 PM Symbiox Inv.& Tradig - Quaterly Results 14 Aug, 4:22 PM Symbiox Inv.& Tradig - Quaterly Results 13 Feb, 12:00 PM Symbiox Inv.& Tradig - Quaterly Results 13 Feb, 12:00 PM Symbiox Investment & Trading Company informs about trading window closure 26 Dec, 5:01 PM Symbiox Investment & Trading Co informs about closure of trading window 23 Sep, 3:49 PM Symbiox Investment & Trading Co informs about newspaper publication 8 Sep, 4:50 PM Symbiox Investment & Trading Company informs about annual secretarial compliance report 12 May, 5:11 PM Symbiox Investment & Trading Co informs about closure of trading window 30 Mar, 4:07 PM Symbiox Investment & Trading Company informs about outcome of EGM 21 Mar, 4:50 PM Symbiox Investment & Trading Company informs about newspaper publication 23 Feb, 4:18 PM Symbiox Inv.& Tradig - Quaterly Results 30 Jan, 5:00 PM Symbiox Inv.& Tradig - Quaterly Results 30 Jan, 5:00 PM Symbiox Inv.& Tradig - Quaterly Results 30 Jan, 5:00 PM Symbiox Investment & Trading Company informs about press release 23 Jan, 2:24 PM Symbiox Investment & Trading Company informs about board meeting 21 Jan, 2:43 PM Symbiox Inv.& Tradig - Quaterly Results 1 Aug, 4:56 PM Symbiox Inv.& Tradig - Quaterly Results 1 Aug, 4:56 PM Symbiox Inv.& Tradig - Quaterly Results 1 Aug, 4:56 PM Symbiox Investment & Trading Company informs about compliances-certificate 19 Jul, 3:06 PM Symbiox Investment & Trading Company informs about closure of trading window 30 Jun, 2:53 PM Symbiox Investment & Trading Company informs about disclosure of related party transactions 13 Jun, 3:55 PM Symbiox Investment & Trading Company informs about newspaper publication 31 May, 4:38 PM Symbiox Investment & Trading Co informs about board meeting 19 Jan, 4:44 PM Symbiox Inv.& Tradig - Quaterly Results 3 Nov, 5:17 PM Symbiox Investment & Trading Co informs about board meeting 23 Oct, 3:55 PM Symbiox Investment & Trading Company informs about scrutinizer's report 1 Oct, 2:49 PM Symbiox Investment & Trading Company informs about 42nd AGM 7 Sep, 5:06 PM Symbiox Investment & Trading Company informs about book closure 7 Sep, 4:39 PM Symbiox Investment & Trading Co informs about half yearly compliance certificate 29 May, 3:31 PM

Symbiox Inv.& Tradig Stock Price Analysis and Quick Research Report. Is Symbiox Inv.& Tradig an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Symbiox Inv.& Tradig stock price today is Rs 3.43. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Symbiox Inv.& Tradig . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Symbiox Inv.& Tradig has a PE ratio of 56.2295081967213 which is high and comparatively overvalued .

  • Share Price: - The current share price of Symbiox Inv.& Tradig is Rs 3.43. One can use valuation calculators of ticker to know if Symbiox Inv.& Tradig share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Symbiox Inv.& Tradig has ROA of 0.6437 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Symbiox Inv.& Tradig has a Current ratio of 88.3152 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Symbiox Inv.& Tradig has a ROE of 0.6626 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Symbiox Inv.& Tradig has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Symbiox Inv.& Tradig has reported revenue growth of -2.1217 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Symbiox Inv.& Tradig for the current financial year is 0.521285584302421 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Symbiox Inv.& Tradig is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Symbiox Inv.& Tradig is Rs 0.061 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Symbiox Inv.& Tradig in Ticker for free. Also, one can get the intrinsic value of Symbiox Inv.& Tradig by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Symbiox Inv.& Tradig
X